Results 151 to 160 of about 311,363 (330)

Re‐PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long‐acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family ...
Marcin Ufnal   +9 more
wiley   +1 more source

Potential Role of Autonomic Dysfunction in Covid-19 Morbidity and Mortality

open access: yesFrontiers in Physiology, 2020
Rodrigo Del Rio   +5 more
doaj   +1 more source

Enhancing the regulatory function of the autonomic nervous system using sounds with inaudible high-frequency components

open access: yesScientific Reports
The dysregulation of the autonomic nervous system (ANS) activity notably contributes to the onset and progression of numerous diseases, including lifestyle-related and psychiatric disorders.
Koto Jogasaki   +3 more
doaj   +1 more source

Peripheral conduction rate in the sympathetic nervous system of man

open access: green, 1941
E. A. Carmichael   +3 more
openalex   +2 more sources

Immune dysregulation as a key driver of peripartum cardiomyopathy – an exploratory advanced imaging and biomarker study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Physiological postpartum remodelling and the pathological processes involved in peripartum cardiomyopathy (PPCM). 18FDG‐PET‐CT, 18F‐fluorodeoxyglucose positron emission tomography‐computed tomography; CCL3, chemokine (C‐C motif) ligand 3; CMR, cardiovascular magnetic resonance; CRP, C‐reactive protein; CSF‐1, colony‐stimulating factor 1; CXCL10 ...
Julian Hoevelmann   +14 more
wiley   +1 more source

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trial

open access: yesEuropean Journal of Heart Failure, EarlyView.
EMPower the heArt of patients with TermInal Cancer using Cardiac medicines (EMPATICC). eGFR, estomated glomerular filtration rate; EP, endpoint; FCM, ferric carboxymaltose; LVEF, left ventricular ejection fraction; N‐terminal pro‐B‐type natriuretic peptide; PGA, patient global assessment; PoC, proof of concept; QoL, quality of life; UICC, Union for ...
Markus S. Anker   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy